聚胺通路抑制剂 DENSPM 抑制了花红细胞瘤细胞系中的脂质代谢
Hans K Ghayee1, Kaylie A Costa2, Yiling Xu1
1Department of Medicine, Division of Endocrinology, College of Medicine, University of Florida and Malcom Randall VA Medical Center, Gainesville, FL 32608, USA.
糖酸脱酶亚单元B (SDHB) 突变驱动了染细胞瘤 (PPGL) 和偏角细胞瘤 (PGL) 的发展. 一种聚胺代谢抑制剂,DENSPM,破坏脂质通路并减少PPGL细胞中的关键脂质,提供新的治疗途径.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 乳色细胞瘤 (PCCs) 和偏角细胞瘤 (PGLs),统称为PPGLs,是罕见的瘤,通常与酸脱酶子单元B (SDHB) 基因突变有关.
- 目前对转移性PPGL的治疗方法有限,这凸显了对新型治疗策略的需求.
- 之前的研究在SDHB突变PPGL细胞中发现了一个过度活跃的聚胺通路,并在临床前模型中证明了聚胺代谢抑制剂N1,N11-diethylnorspermine (DENSPM) 的有效性.
研究的目的:
- 阐明DENSPM在PCC细胞中发挥抗瘤作用的分子机制.
- 在SDHB缺乏的背景下,研究DENSPM对细胞脂质代谢的影响.
- 在PPGL模型中识别受DENSPM处理影响的特定脂类物种.
主要方法:
- 使用患者衍生的PCC细胞系 (hPheo1) 和一个SDHB-knockdown衍生物 (SDHB_KD).
- 进行RNA测序 (RNAseq) 来分析DENSPM治疗后的基因表达变化.
- 使用液态染色体质谱法 (LC/MS) 进行非向性脂质组分析,以分析脂质变化.
主要成果:
- DENSPM治疗广泛干扰了脂质代谢的多个方面,包括脂肪酸合成,脱和吸收.
- 观察到特定脂质组的显著减少,最显著的是等离子体乙烯脂质.
- RNAseq数据显示,与脂质代谢途径相关的基因发生了广泛的变化.
结论:
- DENSPM治疗显著影响PPGL细胞中的脂质代谢,这表明聚胺和脂质通路之间的关键相互作用.
- 观察到的等离子甲脂的减少可能有助于DENSPM的抗增殖作用.
- 这些发现为针对SDHB突变PPGL中的聚胺代谢提供了机制基础,并表明脂质调节在治疗策略中的潜在作用.
更多相关视频
00:12A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
相关概念视频
Abnormal Proliferation
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
